GLENMARK PHARMACEUTICALS LIMITED group: subsidiaries and structure

Summary

GLENMARK PHARMACEUTICALS LIMITED is the ultimate parent of 4 subsidiaries with LEIs in 3 countries, as reported to GLEIF. 2 are held directly; the others sit below intermediate companies. The largest numbers are in the United States (2), in Switzerland (1) and in Russia (1). No subsidiary has a lapsed LEI, and no link rests on accounts older than 24 months. GLEIF's ISIN mapping lists 1 ISIN for the parent and 0 ISINs for its subsidiaries.

Written from GLEIF data using fixed, reviewed sentence templates.